609 related articles for article (PubMed ID: 2991322)
21. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
[TBL] [Abstract][Full Text] [Related]
22. Mode of action of RU 486.
Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
[TBL] [Abstract][Full Text] [Related]
23. The effects of progesterone receptor blockade in the luteal phase of normal fertile women.
Li TC; Dockery P; Thomas P; Rogers AW; Lenton EA; Cooke ID
Fertil Steril; 1988 Nov; 50(5):732-42. PubMed ID: 3181485
[TBL] [Abstract][Full Text] [Related]
24. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
[TBL] [Abstract][Full Text] [Related]
25. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
[TBL] [Abstract][Full Text] [Related]
26. [Mechanism of LH release with synthetic LH-RH (author's transl)].
Koyama T
Nihon Naibunpi Gakkai Zasshi; 1976 Sep; 52(9):881-97. PubMed ID: 828583
[TBL] [Abstract][Full Text] [Related]
27. The effect of levonorgestrel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology.
Landgren BM; Johannisson E; Aedo AR; Kumar A; Shi YE
Contraception; 1989 Mar; 39(3):275-89. PubMed ID: 2496951
[TBL] [Abstract][Full Text] [Related]
28. The antiprogesterone steroid RU-486 does not impair gonadotropin-stimulated luteal adenylyl cyclase activity or gonadotropin release by pituitary cells.
Rojas FJ; O'Conner JL; Asch RH
J Steroid Biochem; 1985 Dec; 23(6A):1053-8. PubMed ID: 3937946
[TBL] [Abstract][Full Text] [Related]
29. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
30. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
Croxatto HB; Massai MR; Salvatierra AM; Fuentealba B; Croxatto HD; Lähteenmäki P
Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
[TBL] [Abstract][Full Text] [Related]
31. Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effects.
Healy DL; Baulieu EE; Hodgen GD
Fertil Steril; 1983 Aug; 40(2):253-7. PubMed ID: 6307760
[TBL] [Abstract][Full Text] [Related]
32. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
Cameron ST; Thong KJ; Baird DT
Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
[TBL] [Abstract][Full Text] [Related]
33. Response to intermittent RU486 in women.
Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
[TBL] [Abstract][Full Text] [Related]
34. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
35. Why does RU486 fail to prevent implantation despite success in inducing menstruation?
Li TC; Lenton EA; Dockery P; Rogers AW; Cooke ID
Contraception; 1988 Oct; 38(4):401-6. PubMed ID: 3208514
[TBL] [Abstract][Full Text] [Related]
36. Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phase.
Shoupe D; Mishell DR; Lahteenmaki P; Heikinheimo O; Birgerson L; Madkour H; Spitz IM
Am J Obstet Gynecol; 1987 Dec; 157(6):1415-20. PubMed ID: 2827481
[TBL] [Abstract][Full Text] [Related]
37. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
Couzinet B; Le Strat N; Ulmann A; Baulieu EE; Schaison G
N Engl J Med; 1986 Dec; 315(25):1565-70. PubMed ID: 3785321
[TBL] [Abstract][Full Text] [Related]
38. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
[TBL] [Abstract][Full Text] [Related]
39. Pituitary-ovarian function after tubal ligation.
Alvarez-Sanchez F; Segal SJ; Brache V; Adejuwon CA; Leon P; Faundes A
Fertil Steril; 1981 Nov; 36(5):606-9. PubMed ID: 7308505
[TBL] [Abstract][Full Text] [Related]
40. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
Hutchison JS; Zeleznik AJ
Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
